# The ENCIRCLE Trial

Study · id `cardio:ct-nct04153292` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04153292](<https://clinicaltrials.gov/study/NCT04153292>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04153292

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 786 participants.

## Technical summary

Registry record NCT04153292. Non-randomized; no masking; primary purpose treatment. Start 2020-11-12 (actual); primary completion 2027-10-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 786 participants (enrolled count; ClinicalTrials.gov record NCT04153292, source copy `cardio:ctgov-nct04153292-2026-10-06`, retrieved 2026-11-18)
- Started: 2020-11-12 (actual) (ClinicalTrials.gov record NCT04153292, source copy `cardio:ctgov-nct04153292-2026-10-06`, retrieved 2026-11-18)
- Primary completion: 2027-10-10 (anticipated) (ClinicalTrials.gov record NCT04153292, source copy `cardio:ctgov-nct04153292-2026-10-06`, retrieved 2026-11-18)
- Completion: 2031-10-10 (anticipated) (ClinicalTrials.gov record NCT04153292, source copy `cardio:ctgov-nct04153292-2026-10-06`, retrieved 2026-11-18)
- Countries: United States; Australia; Canada; Israel; Netherlands; United Kingdom (ClinicalTrials.gov record NCT04153292, source copy `cardio:ctgov-nct04153292-2026-10-06`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04153292-2026-10-06`, retrieved 2026-11-18)

## The registry's words

- Brief title: The ENCIRCLE Trial
- Acronym: ENCIRCLE
- Condition: Mitral Regurgitation
- Condition: Mitral Valve Insufficiency
- Intervention (Device): SAPIEN M3 valve and dock
- Lead sponsor: Edwards Lifesciences
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: Edwards Lifesciences (`cardio:edwards-lifesciences`)

## Provenance

Content hash: b2f5fa71ea52ef5f45d0851bc7d4db4140ffbe7026474efa05174bfa46daea80
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
